ImmunityBio, Inc. employees and revenue per employee

IBRX · Biotechnology · $6.40B market cap

ImmunityBio, Inc. had 691 employees at the end of fiscal Dec 2025, up 1.6% from a year earlier. Revenue for the year was $113M, up 668.3% from a year earlier, or $164K per employee. Revenue and headcount both grew, and revenue grew faster.

Employees

691

+1.6% YoY

Revenue

$113M

+668.3% YoY

Revenue / employee

$164K

Peer median $457K

Rank in industry

87 of 110

Biotechnology

Headcount against revenue

Both lines start at 100 in the first year we hold, so you can see which one grew faster.

EmployeesRevenueIndexed to 100 in Dec 2016
0139031278063'16'17'18'19'20'21'22'23'24'25Revenue 257473Staff 843

Hover a year for the numbers.

IBRX employees and revenue by fiscal year
Year endingEmployeesRevenuePer employeeStaff YoYRevenue YoY
Dec 2025691$113M$164K+1.6%+668.3%
Dec 2024680$14.7M$22K+8.3%+2270.6%
Dec 2023628$622,000$1K-13.4%+159.2%
Dec 2022725$240,000$331+23.5%-74.3%
Dec 2021587$934,000$2K+243.3%+54.4%
Dec 2020171$605,000$4K+15.5%+1307.0%
Dec 2019148$43,000$291-8.1%-8.5%
Dec 2018161$47,000$292+15.8%+4.4%
Dec 2017139$45,000$324+69.5%+2.3%
Dec 201682$44,000$1K——

Open roles: we have not matched a verified job board for this company yet.

Employees, last six fiscal years
171'20587'21725'22628'23680'24691'25
Revenue per employee, last six fiscal years
$4K'20$2K'21$331'22$1K'23$22K'24$164K'25

ImmunityBio, Inc. against similar companies

The closest industry peers by revenue, from Biotechnology.

CompanyEmployeesRevenueRevenue / employeeShape
ZVRA
Zevra Therapeutics, Inc.
61$106M$1.75MEfficient growth
AGEN
Agenus Inc.
81$114M$1.41MLeaner
GLUE
Monte Rosa Therapeutics, Inc.
150$124M$824KEfficient growth
XNCR
Xencor, Inc.
260$126M$483KEfficient growth
ZYME
Zymeworks Inc.
264$106M$401KLeaner
URGN
UroGen Pharma Ltd.
291$110M$377KHiring ahead
BEAM
Beam Therapeutics Inc.
511$140M$273KEfficient growth
GYRE
Gyre Therapeutics, Inc.
618$117M$189KEfficient growth
IBRX
ImmunityBio, Inc.
691$113M$164KEfficient growth
Every Healthcare company

Questions about ImmunityBio, Inc.

How many employees does ImmunityBio, Inc. have?
ImmunityBio, Inc. reported 691 employees for the fiscal year ending Dec 2025, in the annual report it filed on February 23, 2026. That is up 1.6% from a year earlier.
What is ImmunityBio, Inc.'s revenue per employee?
ImmunityBio, Inc. brought in $113M of revenue in fiscal Dec 2025, which is $164K per employee. That ranks 87 of 110 companies we track in Biotechnology, where the median is $457K.
Where do these numbers come from?
Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.

This page is the filings. The research is a membership.

On the first and third Friday of each month Outpick publishes one stock pick with the full case for owning it, adds it to a live portfolio you can audit, and writes a note when a position closes. A new account gets 21 days of the whole membership with no card, and nothing is charged when it ends.

Think you can pick better than the S&P 500?

Pick 15 stocks, lock them in, and we score them against the index every trading day for ten years. Free, with a public leaderboard.

Enter the challenge

Compare IBRX with the rest of the market

See who earns the most per employee, who is hiring, and who is cutting, across every company we track.

Source: employee counts and revenue as stated in ImmunityBio, Inc.'s annual reports (Form 10-K), latest filed February 23, 2026. This is data, not a recommendation to buy or sell IBRX.